Topic: GlaxoSmithKline plc
GlaxoSmithKline studies batch of swine flu vaccines in Canada over allergy fearsCanadian doctors have been advised not to use a batch of 170,000 doses of swine flu vaccine while authorities investigate reports of allergic reactions among recipients, drug maker GlaxoSmithKline PLC said ...
Human Genome Sciences and GlaxoSmithKline said Monday their experimental lupus treatment passed another key goal on its path to potentially becoming the first new drug for the disease in decades. Shares of Human Genome Sciences soared more than 35 percent on the ...
GlaxoSmithKline and Dynavax announce deal to develop autoimmune and inflammatory disease drugsBritish drug maker GlaxoSmithKline PLC said Wednesday it will pay U.S. biotechnology company Dynavax Technologies Corp. $10 million upfront in a research deal to develop drugs to treat autoimmune and inflammatory ...